REFSYN BIOSCIENCES is a Contract Research Organization (CRO) established in 2012,Pondicherry. We offers a wide range of contract research services to the Industries related to Pharmaceutical, Pre-clinical research companies, Biotechnology, Agricultural industries and Academic like Research institutions, Universities, in addition to Governmental organizations.
We are the leading manufacturer, suppliers and exports of API impurities and metabolites in the form of certified reference standards (CRS). We develop high purity with cost-effective products which surely meets requirements of customer. We synthesized more than 1000 products in our stock. We provide COA, analytical supportive documents such as MASS, NMR and HPLC. We are providing quality service, with focus on reducing time and cost, we understand the customer requirement and working close with them to match their timeline.
Our team experts are specialized in synthesis of DRUG METABOLITES as reference standards. Drug metabolites are the final or intermediate compound of drugs and could formed only in human or animals. These high pure human and animal drug metabolites are essential as reference standards for the pharmacologic/toxicological characterization in early stage drug discovery organizations and pre-clinical research studies and Bio- Analytical Studies. We develop this difficult drug metabolites in easier way with cost-effective manner. We easily develop Cytochrome P450 based drug metabolites which could be used for the LC-MS analysis.
The Company is headed by Dr. Geetha Subramanian, Managing Director and Technical Director of Refsyn Bioeciences. She has almost 15 years experience in the field of developing drug metabolites and impurities. She developed many N-demethylated, N-oxide, Hydroxylated metabolites as well as many API impurities. Recently she synthesized some of difficult molecules like 14(R)-14-hydroxy Claithromycin, Aceclofenac metabolites, Azithromycin metabolites and Mefnamic acid metabolites and many anticancer drug metabolites. Now, she focuses to develop phase-II metabolites such as glucuronides and sulfate conjugates.
In our R&D, we also undertake Research process development services on a contract basis including activities like synthetic possibilities, feasibility study, experimental intend, process development and optimization as well as technology transfer. Our team supports the development of new phase-I & Phase-II metabolites of pharmaceutical and agrichemical as per client requirements on a contract basis and secure their work confidentially.
VISION
To emerge as the leading and most admired research-based company especially in drug metabolite and impurity synthesis.
MISSION
Our mission is to provide passion, pride, and timely quality services and superior customer service to meet the requirements and expectations of each and every customer.
